Description

Hydroxychloroquine, marketed under brand names such as Plaquenil, is an antimalarial and antirheumatic prescription medication available in 200 mg film-coated oral tablets. It is indicated for the treatment and prophylaxis of uncomplicated malaria, as well as the management of acute and chronic rheumatoid arthritis, systemic lupus erythematosus, and chronic discoid lupus erythematosus in eligible patients.

Best for

Patients with rheumatoid arthritis, Patients with systemic lupus erythematosus, Managing acute or chronic rheumatoid arthritis symptoms and Treating systemic or discoid lupus erythematosus

Description

Plaquenil (hydroxychloroquine) is a prescription antimalarial and immunomodulating medication supplied as 200 mg tablets. It is indicated alone or with other anti-arthritic drugs to treat rheumatoid arthritis, manage systemic lupus erythematosus, and treat or prevent specific types of malaria. Manufactured as brand-name Plaquenil by Sanofi Aventis or as generic hydroxychloroquine, it works by modifying immune responses to reduce inflammation, alleviate lupus skin manifestations, and prevent arthritic joint pain and swelling.

Best for

patients with rheumatoid arthritis, patients with systemic lupus erythematosus, managing autoimmune inflammatory conditions and malaria treatment and prevention

Description

Plaquenil (hydroxychloroquine) is a prescription anti-malarial medication offered in 200 mg dosages. Brand-name versions manufactured by Sanofi Aventis as well as generic hydroxychloroquine options are supplied through verified international fulfillment centers and dispensaries, including Candrug Pharmacy in Canada. The medication requires a valid prescription from a licensed healthcare professional and is packaged in quantities ranging from 60 to 120 units.

Best for

Patients with a valid prescription and Treatment and prevention of malaria or related doctor-prescribed indications